Stopping Statins After 70: 13% Had Heart Events
Stopping Statins After 70: 13% Had Heart Events
Stopping Statins After 70: 13% Had Heart Events
Key points
اہم نکات
मुख्य बातें
- About 13% of adults over 70 who stopped taking statins had a heart attack, stroke or died, compared with 9% who kept taking them, a major trial presented at the American Heart Association found.
- The STREAM trial followed 1,880 adults aged 70 and older in Switzerland, France and the Netherlands who were taking statins to prevent a first heart attack or stroke, and its safety board advised those who stopped to talk to their doctors about restarting.
- Stopping met the study's preset safety margin at two years, but the higher event rate — roughly one extra event for every 40 people who stopped — means doctors say there should be no blanket recommendation to quit.
- About 13% of adults over 70 who stopped taking statins had a heart attack, stroke or died, compared with 9% who kept taking them, a major trial presented at the American Heart Association found.
- The STREAM trial followed 1,880 adults aged 70 and older in Switzerland, France and the Netherlands who were taking statins to prevent a first heart attack or stroke, and its safety board advised those who stopped to talk to their doctors about restarting.
- Stopping met the study's preset safety margin at two years, but the higher event rate — roughly one extra event for every 40 people who stopped — means doctors say there should be no blanket recommendation to quit.
- About 13% of adults over 70 who stopped taking statins had a heart attack, stroke or died, compared with 9% who kept taking them, a major trial presented at the American Heart Association found.
- The STREAM trial followed 1,880 adults aged 70 and older in Switzerland, France and the Netherlands who were taking statins to prevent a first heart attack or stroke, and its safety board advised those who stopped to talk to their doctors about restarting.
- Stopping met the study's preset safety margin at two years, but the higher event rate — roughly one extra event for every 40 people who stopped — means doctors say there should be no blanket recommendation to quit.
About 13% of adults over 70 who stopped taking statins had a heart attack, stroke or died, compared with 9% who kept taking them, a major trial presented at the American Heart Association found. The STREAM trial followed 1,880 adults aged 70 and older in Switzerland, France and the Netherlands who were taking statins to prevent a first heart attack or stroke, and its safety board advised those who stopped to talk to their doctors about restarting. Stopping met the study's preset safety margin at two years, but the higher event rate — roughly one extra event for every 40 people who stopped — means doctors say there should be no blanket recommendation to quit. The findings do not apply to people who have already had a heart attack or stroke, and stopping made no difference to muscle pain, falls or quality of life.
About 13% of adults over 70 who stopped taking statins had a heart attack, stroke or died, compared with 9% who kept taking them, a major trial presented at the American Heart Association found. The STREAM trial followed 1,880 adults aged 70 and older in Switzerland, France and the Netherlands who were taking statins to prevent a first heart attack or stroke, and its safety board advised those who stopped to talk to their doctors about restarting. Stopping met the study's preset safety margin at two years, but the higher event rate — roughly one extra event for every 40 people who stopped — means doctors say there should be no blanket recommendation to quit. The findings do not apply to people who have already had a heart attack or stroke, and stopping made no difference to muscle pain, falls or quality of life.
About 13% of adults over 70 who stopped taking statins had a heart attack, stroke or died, compared with 9% who kept taking them, a major trial presented at the American Heart Association found. The STREAM trial followed 1,880 adults aged 70 and older in Switzerland, France and the Netherlands who were taking statins to prevent a first heart attack or stroke, and its safety board advised those who stopped to talk to their doctors about restarting. Stopping met the study's preset safety margin at two years, but the higher event rate — roughly one extra event for every 40 people who stopped — means doctors say there should be no blanket recommendation to quit. The findings do not apply to people who have already had a heart attack or stroke, and stopping made no difference to muscle pain, falls or quality of life.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।